CKD-390

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Chronic Hepatitis B

Phase 1

Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet

CompletedNCT02589457

Chong Kun Dang PharmaceuticalChronic Hepatitis B

Start: 2015-10-31End: 2015-12-31Updated: 2016-01-12

Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet

Chong Kun Dang PharmaceuticalChronic Hepatitis B

Start: 2016-04-30End: 2018-03-31Target: 158Updated: 2016-06-21